

Hims & Hers Health Inc. (NYSE: HIMS) had a busy week that included Q3 earnings miss, a board appointment and analyst price target changes.
You can purchase shares of Hims & Hers Health (NYSE:HIMS) through any online brokerage.
Other companies in Hims & Hers Health’s space includes: CVS Health Corp (NYSE:CVS), The Cigna Group (NYSE:CI), Labcorp Holdings Inc (NYSE:LH), Quest Diagnostics Inc (NYSE:DGX) and Guardant Health Inc (NASDAQ:GH).
Hims & Hers Health has a consensus price target of $30.47.
The stock price for Hims & Hers Health (NYSE: HIMS) is $19.5135 last updated November 11, 2026 at 9:00 AM EST.
There are no upcoming dividends for Hims & Hers Health.
Hims & Hers Health does not have any upcoming earnings scheduled.
There is no upcoming split for Hims & Hers Health.
Hims & Hers Health is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NYSE.
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include...